Impact of postoperative duration of Aspirin use on longevity of bioprosthetic pulmonary valve in patients who underwent congenital heart disease repair

• Main Authors: Tae-Woong Hwang (Author), Sung-Ook Kim (Author), Sang-Yun Lee (Author), Seong-Ho Kim (Author), Eun-Young Choi (Author), So-Ick Jang (Author), Su-Jin Park (Author), Hye-Won Kwon (Author), Hyo-Bin Lim (Author), Chang-Ha Lee (Author), Eun-Seok Choi (Author)
• Format: Book
• Published: Korean Pediatric Society, 2016-11-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

PurposeGenerally, aspirin is used as a protective agent against thrombogenic phenomenon after pulmonary valve replacement (PVR) using a bioprosthetic valve. However, the appropriate duration of aspirin use is unclear. We analyzed the impact of postoperative duration of aspirin use on the longevity o...